Diseases, Conditions, Syndromes

FDA clears investigational drug for ALS gene therapy trials

Apic Bio, a gene therapy company developing treatment options for patients with rare genetic diseases and co-founded by UMass Medical School's Robert H. Brown Jr., DPhil, MD, announced that the FDA has cleared its investigational ...